Home › Studies › PRJNA898628
PRJNA898628 SRP406567

Probiotic effects in preterm infants, Norway

PINGU Fecal samples Metagenome

Longitudinal cohort study of 220 fecal samples from extremely preterm infants/neonates in Norway, examining how probiotic supplementation reshapes gut microbiota, resistome, and mobilome networks following antibiotic exposure. machine-written summary

220 samples · 220 runs · NO · Infant / toddler · 2023 · 0.75 Gbp / sample

Sources
✓Sequence archive 646○Abstract / description✓Full text 323✓Supplementary tables 1,483–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive646 sample values (collection date, country, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
✓ Full text323 sample values (location region, preterm status) · PMC10192547, PMC11929092
✓ Supplementary tables1,483 sample values (age, antibiotic exposure, birth weight grams, delivery mode, feeding mode, gestational age weeks, health condition, health condition detail)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Probiotic (live microorganisms; single strain or mixture) design observational_with_procedure · population preterm_nicu · Probiotic supplementation in extremely preterm infants; cohort also had routine antibiotic exposure

“probiotic-supplemented and antibiotic-exposed extremely preterm infants” — abstract:37187112 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
infant133
neonate87
Condition
preterm_nicu104
Country
NO220
Body site
primary220
Collected 2015–2016
2015: 123 samples2016: 97 samples20152016
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 2 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 1 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 7 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 154 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 20 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 10 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 26 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.75 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

70 of 72 people sampled more than once (218 samples; median 3, up to 4 per person) · follow-up median 4 d (max 12 mo) · median interval between samples 2 d (time from collection dates).

EP-15EP-15: day 0EP-15: day 2EP-15: day 4EP-2EP-2: day 0EP-2: day 2EP-2: day 4EP-30EP-30: day 0EP-30: day 2EP-30: day 4EP-30: day 6EP-36EP-36: day 0EP-36: day 21EP-36: day 113EP-36: day 358EP-4EP-4: day 0EP-4: day 6EP-4: day 8EP-4: day 10EP-40EP-40: day 0EP-40: day 2EP-40: day 4EP-40: day 6EP-46EP-46: day 0EP-46: day 2EP-46: day 4EP-5EP-5: day 0EP-5: day 21EP-5: day 113EP-55EP-55: day 0EP-55: day 2EP-55: day 4EP-56EP-56: day 0EP-56: day 2EP-56: day 4EP-62EP-62: day 0EP-62: day 2EP-62: day 4EP-63EP-63: day 0EP-63: day 2EP-63: day 4EP-66EP-66: day 0EP-66: day 2EP-66: day 4EP-66: day 6EP-68EP-68: day 0EP-68: day 2EP-68: day 4EP-68: day 6EP-9EP-9: day 0EP-9: day 2EP-9: day 4FT-59FT-59: day 0FT-59: day 2FT-59: day 4FT-59: day 6FT-60FT-60: day 0FT-60: day 2FT-60: day 4FT-69FT-69: day 0FT-69: day 2FT-69: day 4FT-69: day 6FT-72FT-72: day 0FT-72: day 2FT-72: day 4FT-72: day 6FT-74FT-74: day 0FT-74: day 2FT-74: day 4FT-74: day 6VP1-11VP1-11: day 0VP1-11: day 2VP1-11: day 4VP1-11: day 6VP1-13VP1-13: day 0VP1-13: day 2VP1-13: day 4VP1-13: day 6VP1-21VP1-21: day 0VP1-21: day 2VP1-21: day 4VP1-21: day 6VP1-23VP1-23: day 0VP1-23: day 2VP1-23: day 4VP1-23: day 6VP1-41VP1-41: day 0VP1-41: day 2VP1-41: day 4VP1-41: day 6VP1-43VP1-43: day 0VP1-43: day 2VP1-43: day 4VP1-43: day 6VP1-52VP1-52: day 0VP1-52: day 2VP1-52: day 4VP1-52: day 6VP1-53VP1-53: day 0VP1-53: day 2VP1-53: day 4VP1-53: day 6VP1-6VP1-6: day 0VP1-6: day 2VP1-6: day 4VP1-6: day 14VP1-64VP1-64: day 0VP1-64: day 2VP1-64: day 4VP1-64: day 6VP1-65VP1-65: day 0VP1-65: day 2VP1-65: day 4VP1-65: day 6VP1-7VP1-7: day 0VP1-7: day 2VP1-7: day 4VP1-7: day 6VP2-10VP2-10: day 0VP2-10: day 2VP2-10: day 4VP2-10: day 6VP2-16VP2-16: day 0VP2-16: day 2VP2-16: day 4VP2-16: day 6VP2-17VP2-17: day 0VP2-17: day 2VP2-17: day 4VP2-17: day 6VP2-25VP2-25: day 0VP2-25: day 2VP2-25: day 4VP2-25: day 60 d3 mo6 mo9 mo12 mo

Each row is one person (36 shown of 70); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Bifidobacterium 21.7%Bacteroides 11.5%Phocaeicola 9.1%Escherichia 6.8%Faecalibacterium 3.5%Klebsiella 3.4%Mediterraneibacter 3.3%Veillonella 2.9%Akkermansia 2.2%Alistipes 2.2%Roseburia 2.2%Blautia_A 1.8%not assigned to a genus 2.7%other genera 26.6%

Genera, mean relative abundance over 52 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category220 100%
country220 100%220
health_condition104 47%104
subject_id220 100%103117
collection_date220 100%220
detailed_location220 100%
location_region220 100%220
preterm_status220 100%117103
timepoint_label220 100%103117
age_at_collection_days117 53%117
antibiotic_exposure117 53%117
birth_weight_grams117 53%117
delivery_mode117 53%117
feeding_mode117 53%117
gestational_age_weeks117 53%117
lifestyle117 53%117
maternal_antibiotics105 48%105
health_condition_detail104 47%104
Papers (2)
  • Development of early life gut resistome and mobilome across gestational ages and microbiota-modifying treatments. PMID 37187112 PMC10192547 curated
  • Dynamics of gut resistome and mobilome in early life: a meta-analysis. PMID 40048849 PMC11929092 curated
Details
Archive description

Probiotic supplementation reshapes antibiotic-impaired gut microbiota, resistome, and mobilome networks in extremely preterm infants

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of neonate and infant / toddler by opus_adjudicated with confidence 0.60. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host study.description · “extremely preterm infants”
  • body site study.title · “PINGU Fecal samples Metagenome”
  • life stage study.description · “extremely preterm infants”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN31618465age_at_collection_days28R20.75paper.supp.tableinfant_age=28
SAMN31618465antibiotic_exposureyesR20.75paper.supp.tableantibiotics_current_use=yes
SAMN31618465birth_weight_grams625R20.75paper.supp.tablebirth_weight=625
SAMN31618463collection_date2015-05-01R10.85biosample.attribute:collection_datecollection_date: 2015-05-01
SAMN31618463countryNOR10.90biosample_attrNorway
SAMN31618465delivery_modec_sectionR20.75paper.supp.tableborn_method=c_section
SAMN31618465feeding_modeexclusive_breastR20.75paper.supp.tablefeeding_practice=exclusive breastfeeding
SAMN31618465gestational_age_weeks26.0R20.75paper.supp.tablegestational_age=26
SAMN31618465health_conditionpreterm_nicuR20.85paper.supp.mmc1.xlsx[Table S2][premature]sample_id=SRR22213046; premature: yes
SAMN31618465health_condition_detailyesR20.85paper.supp.mmc1.xlsx[Table S2][premature]sample_id=SRR22213046; premature: yes
SAMN31618465lifestyleurban_industrializedR20.85paper.supp.mmc1.xlsx[Table S2][lifestyle]sample_id=SRR22213046; lifestyle: industrialized
SAMN31618463location_regionunstatedR30.70paper.fulltext.methodssix neonatal intensive care units (NICUs) in Norway
SAMN31618465maternal_antibioticsnoR20.75paper.supp.tablematernal_abx=no
SAMN31618465preterm_statuspretermR20.75paper.supp.tablepremature=yes
SAMN31618463preterm_statuspretermR30.50paper.fulltext.abstractextremely preterm infants
SAMN31618463subject_idEP-15R10.70sample.name_rule:sample_aliasEP-15-1-Day7_R1
SAMN31618465subject_idEP-15R20.75paper.supp.tablesubject_id=EP-15
SAMN31618463timepoint_labelDay7R10.70sample.name_rule:sample_aliasEP-15-1-Day7_R1
SAMN31618465timepoint_label2R20.85paper.supp.mmc1.xlsx[Table S2][visit_number]sample_id=SRR22213046; visit_number: 2
Sequencing

220 runs over 220 samples · mean 2.45 Gbp per run (median 0.75 Gbp, total 538.08 Gbp; 220 runs with a base count) · layout PAIRED 220 · platform ILLUMINA 220 · models Illumina MiSeq (220) · 24% of runs with a Sandpiper profile · first public 2023-06-05

Authors (14)

Bargheet A first · Klingenberg C · Esaiassen E · Hjerde E · Cavanagh JP · Bengtsson-Palme J · Pettersen VK last · Noordzij HT · Ponsero AJ · Jian C · Korpela K · Valles-Colomer M · Debelius J · Kurilshikov A

Downloads

PRJNA898628.csv.gz (8.9 KB) · parquet (83.0 KB) — all 220 samples, every field with route and confidence · PRJNA898628_determinations.csv.gz (23.1 KB) — 2,452 evidence rows

Samples (220 · every field this project has values for · hover a cell for its source)
Loading the sample table…